Sunday, 12 July 2020
Jakarta
--:--
Tokyo
--:--
Hongkong
--:--
New York
--:--
First Human Trial of Potential COVID-19 Vaccine Underway in Australia
Wednesday, 27 May 2020 17:52 WIB | GLOBAL |Global

The southern hemisphere's first human trials of a potential coronavirus vaccine have started in Australia.  131 people aged between 18-59 are involved in the program in Melbourne and Brisbane.          

The potential vaccine, NVX-CoV2373, is being developed by the American biotech company Novavax. It started working on the drug in January when the COVID-19 outbreak began in China. It aims to boost the body's immune response and stimulate high levels of neutralizing antibodies. 

If the vaccine works, researchers hope 100 million doses can be made by the end of this year and 1.5 billion next year.

Researchers say that "vaccines are miracles and have a great way of protecting populations against these severe diseases."

Dr Paul Griffin is an infectious diseases expert who is involved in the Australian COVID 19 trial.  He hopes the drug will successfully attack the virus and be ready for use within months.  

"We look for antibodies and the type and number of antibodies, and then we take some things out of the subjects through those blood tests and do a lot of laboratory experiments to show that it neutralizes the virus.  The company manufacturing the vaccine have already started that scaling-up process, so they are already making a lot of doses of this vaccine.  So if we can prove it is safe and effective then, potentially, by the end of the year there will be significant number of doses available," Griffin said. 

Australian authorities say the trial is a significant step forward in the global race for a coronavirus vaccine.  Some participants will receive a placebo while others will be administered Novavax's drug.

Early results are expected in July, and scientists expect "some conclusive results by the end of this year".  Phase two trials would take place with thousands of volunteers in several countries.  Volunteers are still needed, and the research team has stressed that no live coronavirus is used in experiments on people.

Novavax has received $388 million from the Norway-based Coalition for Epidemic Preparedness Innovations.  There are more than 100 potential coronavirus vaccines in development, and about a dozen have made it to the human trial stage.  

It is a global race potentially worth billions of dollars to those who can find a safe and reliable treatment for a virus that has killed almost 350,000 people around the world.

Source : VOA

RELATED NEWS
Seoul Mayor Found Dead Friday; Suicide Suspected...
Friday, 10 July 2020 23:43 WIB

South Korean police say Seoul Mayor Park Won-soon was found dead early Friday, a suspected suicide. The body of 64-year-old Park was found near an entrance at the mountain Bugaksan in Seoul after jus...

North Korea Says It's Not Interested in Another Trump-Kim Summit...
Friday, 10 July 2020 17:50 WIB

North Korea says the chances are low for another summit with the United States, after President Donald Trump this week said he is open to meeting again with North Korean leader Kim Jong Un. Kim Yo Jo...

WHO Launches Independent Pandemic Response Evaluation Panel...
Friday, 10 July 2020 10:45 WIB

The World Health Organization Thursday named former New Zealand Prime Minister Helen Clark and former Liberian President Ellen Johnson Sirleaf to lead an independent panel to evaluate the agency™s r...

Australia Suspends Extradition Treaty with Hong Kong...
Thursday, 9 July 2020 23:31 WIB

Australia is suspending its extradition treaty with Hong Kong in response to the new national security law imposed on the city by China. In announcing the move Thursday, Prime Minister Scott Morrison...

US COVID-19 Cases Rising, But Deaths Flat, for Now...
Thursday, 9 July 2020 17:09 WIB

The number of people infected with the coronavirus is rising sharply in the United States. But the number of people dying is flat. It sounds like good news. But experts warn against reading too much ...

LATEST NEWS
Dow ends nearly 370 points higher as Nasdaq logs another record close

Stocks ended higher in thin trade Friday, getting a lift from positive news on a coronavirus treatment. The Dow Jones Industrial Average rose around 369 points, or 1.4%, to end near 26,075, according to preliminary figures, while the S&P 500...

Hong Kong Stocks End With Deep Losses (Review)

Hong Kong stocks closed sharply lower Friday, in line with an Asia-wide sell-off, with investors also spooked by fresh infections in the city that have led to the reimposition of containment measures including school closures. The Hang Seng Index...

Oil climbs, but U.S. benchmark ends lower for the week as IEA warns of coronavirus risk

Oil futures climbed on Friday, buoyed by positive results tied to a COVID-19 treatment, but U.S. prices ended lower for the week as a report from the International Energy Agency cautioned that weaker demand caused by the coronavirus pandemic will...

POPULAR NEWS
Gold futures pull back from a fresh 9-year peak, but hold above $1,800 an ounce
Friday, 10 July 2020 01:31 WIB

Gold futures ended lower on Thursday, pulling back a day after scoring another settlement at the highest since September 2011, but the haven metal...

Gold Futures Slip, Set to Take a Breather after Carving Out Fresh 9-Year Peak
Thursday, 9 July 2020 18:57 WIB

Gold futures edged back early Thursday, giving up some of its gains after the precious metal scored another settlement at the highest since...

Hong Kong Stocks Close On Strong Note
Thursday, 9 July 2020 15:25 WIB

Hong Kong stocks finished with more gains on Thursday, in line with advances across Asia following another record-breaking lead from Wall...

Gold Heads for Fifth Weekly Advance Amid Virus Sparks
Friday, 10 July 2020 16:48 WIB

Gold hovered above its key $1,800-an-ounce mark, on course for a fifth weekly advance, as investors weighed concern over a resurgence in...